Skip to main content
. 2017 May 3;31(3):381–386. doi: 10.21873/invivo.11070

Figure 2. Kaplan–Meier plot for all-cause mortality for soluble urokinase plasminogen activator receptor (suPAR) concentration. Patients with higher (>3 ng/ml) suPAR levels had higher probability for all-cause mortality (p<0.05) during the 5-year followup period.

Figure 2